|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sangodkar J, Katz S, Melville H and Narla
G: Lung adenocarcinoma: Lessons in translation from bench to
bedside. Mt Sinai J Med. 77:597–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vansteenkiste J, Crinò L, Dooms C,
Douillard JY, Faivre-Finn C, Lim E, Rocco G, Senan S, Van Schil P,
Veronesi G, et al: 2nd ESMO consensus conference on lung cancer:
Early-stage non-small-cell lung cancer consensus on diagnosis,
treatment and follow-up. Ann Oncol. 25:1462–1474. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chabowski M, Polański J,
Jankowska-Polanska B, Lomper K, Janczak D and Rosinczuk J: The
acceptance of illness, the intensity of pain and the quality of
life in patients with lung cancer. J Thorac Dis. 9:2952–2958. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huo Y, Li A and Wang Z: LncRNA AWPPH
participates in the metastasis of non-small cell lung cancer by
upregulating TGF-β1 expression. Oncol Lett. 18:4246–4252.
2019.PubMed/NCBI
|
|
7
|
NSCLC Meta-analysis Collaborative Group, :
Preoperative chemotherapy for non-small-cell lung cancer: A
systematic review and meta-analysis of individual participant data.
Lancet. 383:1561–1571. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Borghaei H, Paz-Ares L, Horn L, Spigel DR,
Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, et al:
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell
lung cancer. N Engl J Med. 373:1627–1639. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frank L, Christodoulou E and Kazerooni EA:
Radiation risk of lung cancer screening. Semin Respir Crit Care
Med. 34:738–747. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chalela R, Curull V, Enríquez C, Pijuan L,
Bellosillo B and Gea J: Lung adenocarcinoma: From molecular basis
to genome-guided therapy and immunotherapy. J Thorac Dis.
9:2142–2158. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jabeen R, Goswami R, Awe O, Kulkarni A,
Nguyen ET, Attenasio A, Walsh D, Olson MR, Kim MH, Tepper RS, et
al: Th9 cell development requires a BATF-regulated transcriptional
network. J Clin Invest. 123:4641–4653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Murphy TL, Tussiwand R and Murphy KM:
Specificity through cooperation: BATF-IRF interactions control
immune-regulatory networks. Nat Rev Immunol. 13:499–509. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hernandez JM, Floyd DH, Weilbaecher KN,
Green PL and Boris-Lawrie K: Multiple facets of junD gene
expression are atypical among AP-1 family members. Oncogene.
27:4757–4767. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wagner EF and Eferl R: Fos/AP-1 proteins
in bone and the immune system. Immunol Rev. 208:126–140. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schleussner N, Merkel O, Costanza M, Liang
HC, Hummel F, Romagnani C, Durek P, Anagnostopoulos I, Hummel M,
Jöhrens K, et al: The AP-1-BATF and -BATF3 module is essential for
growth, survival and TH17/ILC3 skewing of anaplastic large cell
lymphoma. Leukemia. 32:1994–2007. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dai L, Cui X, Zhang X, Cheng L, Liu Y,
Yang Y, Fan P, Wang Q, Lin Y, Zhang J, et al: SARI inhibits
angiogenesis and tumour growth of human colon cancer through
directly targeting ceruloplasmin. Nat Commun. 7:119962016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gil M, Pak HK, Park SJ, Lee AN, Park YS,
Lee H, Lee H, Kim KE, Lee KJ, Yoon DH, et al: Engagement of CD99
reduces AP-1 activity by inducing BATF in the human multiple
myeloma cell line RPMI8226. Immune Netw. 15:260–267. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duruisseaux M and Esteller M: Lung cancer
epigenetics: From knowledge to applications. Semin Cancer Biol.
51:116–128. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zarogoulidis P, Tsakiridis K, Karapantzou
C, Lampaki S, Kioumis I, Pitsiou G, Papaiwannou A,
Hohenforst-Schmidt W, Huang H, Kesisis G, et al: Use of proteins as
biomarkers and their role in carcinogenesis. J Cancer. 6:9–18.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marchetti A, Felicioni L, Malatesta S,
Grazia Sciarrotta M, Guetti L, Chella A, Viola P, Pullara C,
Mucilli F and Buttitta F: Clinical features and outcome of patients
with non-small-cell lung cancer harboring BRAF mutations. J Clin
Oncol. 29:3574–3579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He L, Zhang Y, Sun H, Jiang F, Yang H, Wu
H, Zhou T, Hu S, Kathera CS, Wang X, et al: Targeting DNA flap
endonuclease 1 to impede breast cancer progression. EBioMedicine.
14:32–43. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thomas C, Ji Y, Lodhi N, Kotova E, Pinnola
AD, Golovine K, Makhov P, Pechenkina K, Kolenko V and Tulin AV:
Non-NAD-like poly(ADP-ribose) polymerase-1 inhibitors effectively
eliminate cancer in vivo. EBioMedicine. 13:90–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dorsey MJ, Tae HJ, Sollenberger KG,
Mascarenhas NT, Johansen LM and Taparowsky EJ: B-ATF: A novel human
bZIP protein that associates with members of the AP-1 transcription
factor family. Oncogene. 11:2255–2265. 1995.PubMed/NCBI
|
|
27
|
Ise W, Kohyama M, Schraml BU, Zhang T,
Schwer B, Basu U, Alt FW, Tang J, Oltz EM, Murphy TL and Murphy KM:
The transcription factor BATF controls the global regulators of
class-switch recombination in both B cells and T cells. Nat
Immunol. 12:536–543. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schraml BU, Hildner K, Ise W, Lee WL,
Smith WA, Solomon B, Sahota G, Sim J, Mukasa R, Cemerski S, et al:
The AP-1 transcription factor Batf controls T(H)17 differentiation.
Nature. 460:405–409. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma QY, Huang DY, Zhang HJ, Wang S and Chen
XF: Upregulation of bacterial-specific Th1 and Th17 responses that
are enriched in CXCR5+CD4+ T cells in
non-small cell lung cancer. Int Immunopharmacol. 52:305–309. 2017.
View Article : Google Scholar : PubMed/NCBI
|
